Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 50, Issue 51, 2003, Pages 809-813

  Maeda, Seishi ^a   Shibata, Junji ^a   Fujiyama, Shigetoshi ^a   Tanaka, Motohiko ^a   Noumaru, Shinji ^a   Sato, Kinmochi ^a   Tomita, Kimio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoembolization; Cisplatin; Hepatocellular carcinoma (HCC); Long term follow up; Transcatheter Arterial Embolization (TAE)

Indexed keywords

CISPLATIN; GRANISETRON; IODINATED POPPYSEED OIL; METHYLPREDNISOLONE; METOCLOPRAMIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CAUSE OF DEATH; CELIAC ANGIOGRAPHY; DRUG FORMULATION; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEPATIC ARTERY; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; SUSPENSION; TUMOR GROWTH; TUMOR VOLUME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HEPATIC ARTERY; HUMANS; INJECTIONS, INTRA-ARTERIAL; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; SUSPENSIONS; TREATMENT OUTCOME;

EID: 0038238713     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Nakakuma K, Tashiro S, Uemura K, et al: Studies on the anticancer treatment with oily anticancer drug injected into the ligated hepatic artery for liver cancer. Nichidoku Iho 1979; 24:675-682. (In Japanese)
2. Nakakuma K, Tashiro S, Hiraoka T, et al: Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer. Cancer 1983; 52:2193-2200.
3. Konno T, Maeda H, Iwai K, et al: Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: A preliminary report. Eur J Cancer Clin Oncol 1983; 19:1053-1065.
4. Iwai K, Maeda H, Konno T: Use of oily contrast medium for selective drug targeting to tumor: Enhanced therapeutic effect and X-ray image. Cancer Res 1984; 44:2115-2121.
5. Kanematsu T, Inokuchi K, Sugimachi K, et al: Selective effects of Lipiodolized anticancer agents. J Surg Oncol 1984; 25:218-226.
6. Ohishi H, Uchida H, Yoshimura H, et al: Hepatocellular carcinoma detected by iodized oil: Use of anticancer agents. Radiology 1985; 154:25-29.
7. Yamashita Y, Nakagawa N, Miyazaki M, et al: Experimental study of hepatic arterial embolization therapy by various formulation of anticancer agent-Lipiodol. Nippon Acta Radiol 1985; 45:1313-1321. (In Japanese)
8. Kobayashi H, Hidaka H, Kajiya Y, et al: Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution. Acta Radiol 1986; 27:139-147.
9. Fukushima S, Kawaguchi T, Nishida M, et al: Selective anticancer effects of 3′, 5′-dioctanoyl-5-fluoro-2′-deoxyuridine, a lipophilic prodrug of 5-fluoro-2′-deoxyuridine, dissolved in an oily lymphographic agent on hepatic cancer of rabbits bearing VX-2 tumor. Cancer Res 1987; 47:1930-1934.
10. Melia WM, Westaby D, Williams R: Diamminodichloride platinum (cis-platin) in the treatment of hepatocellular carcinoma. Clin Oncol 1981; 7:275-280.
11. Falkson G, Ryan LM, Johnson LA, et al: A random phase II study of mitoxantronand cisplatin in patients with hepatocellular carcinoma: An ECOG study. Cancer 1987; 60:2141-2145.
12. Ravry MJR, Omura GA, Bartolucci AA, et al: Phase II evaluation of cisplatin in advanced hepatocellular carcinoma and cholangiocarcinoma: A Southeastern Cancer Study Group trial. Cancer Treat Rep 1986; 70:311-312.
13. Maeta M, Koga S, Yoshioka H, et al: Intra-hepato-arterial infusions of cis-diamminedichloro-platinum (II) and 5-fluorouracil clinically effective for malignant liver tumor. Jpn J Surg 1985; 15:318-320.
14. Kajanti M, Rissanen R, Virkkunen P, et al: Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma: A phase II study. Cancer 1986; 58:2386-2388.
15. Sasaki Y, Imaoka S, Kasugai H, et al: A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 1987; 60:1194-1203.
16. Shibata J, Fujiyama S, Sato T, et al: Hepatic arterial Injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer 1989; 64:1586-1594.
17. Fukushima S, Kishimoto S, Hayashi Y, et al: Intrahepatic artery infusional chemotherapy with cisplatin suspension in Lipiodol (LPS) for hepatocellular carcinoma: preparation of LPS and its anticancer effect on rabbit liver cancer model after injection into the hepatic artery.J Jpn Soc Cancer Ther 1988; 23:2743-2749. (In Japanese)
18. Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148:397-401.
19. Yamashita F, Tanaka M, Andou E, et al: Carboplatin as an anticancer agent for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: Oncology 1997; 54:28-33.
20. Okusaka T, Okada S, Ishii H, et al: Transarterial chemotherapy with zinostatin stimalamer for hepatocellular carcinoma. Oncology 1998; 55:276-283.
21. Kanematsu M: Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hapatocellular carcinoma. J Gastroenterol 1995; 30:215-223.
22. Fujiyama S, Morishita T, Hashiguchi O, et al: Plasma abnormal prothrombin (des-y-carboxy prothrombin) as a marker of hepatocellular carcinoma. Cancer 1988; 61:1621-1628.
23. American Joint Committee on Cancer: Manual for Staging of Cancer, Edition 3. Philadelphia: JB Lippincott, 1988; pp. 87-92.
24. Kaplan EL, Meier P: Nonparametric estimation from in complete observations. J Am Stat Assoc 1958; 53:457-481.
25. Liver Cancer Study Group of Japan: Survey and follow-up study of primary liver cancer in Japan-Report 13-. Acta Hepato Jap 1999; 40:288-300. (In Japanese)
26. Bruix J, Llovet JM, Casrells A, et al: Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution. Hepatology 1998; 27:1578-1583.
27. Pelletier G, Roche A, Ink O, et al: A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 1990; 11:181-184.
28. Okusaka T, Okada S, Ishii H, et al: Phase II study of transcatheter embolization using zinostatinstimalamer (SMANCS) and gelatin sponge for hepatocellular carcinoma. Proc Am Soc Clin Oncol 1998; 17:266a,
29. Beppu T, Ohara C, Yamaguchi Y, et al: A new approach to chemoembolization for unresectable hapatocellular carcinoma using aclarubicin microspheres in combination with cisplatin suspended in iodized oil. Cancer 1991; 68:2555-2560.